Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults
Top Cited Papers
Open Access
- 8 May 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (9) , 1321-1326
- https://doi.org/10.1001/archinte.160.9.1321
Abstract
MORE THAN 50% of Americans are overweight or obese, with 20% classified as obese (body mass index [BMI] [calculated as weight in kilograms divided by the square of height in meters] [BMI] ≥30), according to recently established National Institutes of Health body weight guidelines.1 An important consequence of excessive adiposity is type 2 diabetes mellitus,2,3 a condition that is associated with an increased risk of mortality and morbidity.4 Furthermore, the incidence and prevalence of obesity and diabetes are increasing worldwide, especially in developing and newly industrialized nations. The estimated 80 million persons with diabetes in 1990 is expected to double by the year 2000, becoming a global epidemic, and the major part of the increase will occur in developing countries.3 Over 12 million Americans are now overweight or obese and have type 2 diabetes.3Keywords
This publication has 14 references indexed in Scilit:
- Orlistat in the Long-term Treatment of Obesity in Primary Care SettingsArchives of Family Medicine, 2000
- Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?Diabetes Care, 1999
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive SummaryThe American Journal of Clinical Nutrition, 1998
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patientsPublished by Elsevier ,1998
- The World Health Report 1997: conquering suffering, enriching humanityRevista Panamericana de Salud Pública, 1997
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart DiseaseNew England Journal of Medicine, 1996
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 1995
- Caloric Restriction Per Se Is a Significant Factor in Improvements in Glycemic Control and Insulin Sensitivity During Weight Loss in Obese NIDDM PatientsDiabetes Care, 1994
- The Natural History of Impaired Glucose Tolerance in the Pima IndiansNew England Journal of Medicine, 1988